MwanzoMBIO • NASDAQ
add
Mustang Bio Inc
$Â 0.20
Kabla ya soko:(1.00%)+0.0020
$Â 0.20
Imefungwa: 27 Nov, 08:00:06 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$Â 0.20
Bei za siku
$Â 0.18 - $Â 0.21
Bei za mwaka
$Â 0.13 - $Â 1.68
Thamani ya kampuni katika soko
9.80M USD
Wastani wa hisa zilizouzwa
3.36M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 1.46M | -87.50% |
Mapato halisi | -1.41M | 85.98% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.04 | 97.14% |
EBITDA | -1.41M | 87.64% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.52M | -63.14% |
Jumla ya mali | 7.19M | -65.03% |
Jumla ya dhima | 15.85M | -4.28% |
Jumla ya hisa | -8.66M | — |
hisa zilizosalia | 47.72M | — |
Uwiano wa bei na thamani | -0.85 | — |
Faida inayotokana na mali | -46.37% | — |
Faida inayotokana mtaji | 48.83% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.41M | 85.98% |
Pesa kutokana na shughuli | -1.76M | 85.39% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | 1.01M | 305.60% |
Mabadiliko halisi ya pesa taslimu | elfu -743.00 | 87.24% |
Mtiririko huru wa pesa | -1.20M | 51.19% |
Kuhusu
Mustang Bio is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2015
Makao Makuu
Tovuti
Wafanyakazi
80
